Philips (NYSE:PHG) has issued corrections for some of its Trilogy Evo ventilator platforms due to multiple issues.
The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results